Skip to content

proGAV® FV442TRecalls & reported problems

Christoph Miethke GmbH & Co. KG · PROGAV SYS PED.W/SA 25 A.PRECHAMBER · Class 2 · Implant

All models of proGAV (28)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04041906132552), received between Jul 12, 2021 and Jul 12, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Infusion or Flow Problem1

Patient problems

  • Hydrocephalus1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 12, 2021Infusion or Flow Problem; Infusion or Flow Problem

    IT WAS REPORTED THAT A PROGAV (PART # FV442T) WAS IMPLANTED DURING A PROCEDURE PERFORMED IN (B)(6) OR (B)(6) . ACCORDING TO THE COMPLAINANT, THE SHUNT SYSTEM WAS BELIEVED TO BE OPERATING IN UNDERDRIANAGE. THE PATIENT UNDERWENT A REVISION PROCEDURE ON (B)(6) 2021. THE COMPLAINT DEVICE WAS RETURNED TO THE MANUFACTURER FOR EVALUATION. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE REVISION PROCEDURE. AGE: (B)(6) HEIGHT: (B)(6) ) WEIGHT: (B)(6) GENDER: FEMALE.

    Patient problems: Hydrocephalus

    MAUDE report 12149824 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page